06Jun
Supreme Court Decides Prescription Drug Preemption Case in Favor of Drug Manufacturer
The United States Supreme Court finally clarified its 11-year-old “clear evidence” standard for pharmaceutical preemption. In its much-anticipated opinion delivered by Justice Breyer, the Court unanimously reversed the Third Circuit’s holding that...
By:
Morrison & Foerster LLP - Class Dismissed
Related
Spoiler Alert – unless you regularly deal with collective bargaining agreements you may find this a...
Read More >
On Sunday June 21, 2020, the Mexican Banking and Securities Commission ("CNBV") ?in charge of the an...
Read More >
The Internal Revenue Service set March 31, 2020 as the last date of the remedial amendment period fo...
Read More >
The SEC has adopted amendments to the financial disclosure requirements in Regulation S-X for acquis...
Read More >
HR Professionals will soon know the answer to this question. The United States Supreme Court is pr...
Read More >
On December 30, 2019, Vice Chancellor Joseph R. Slights III of the Delaware Court of Chancery dismis...
Read More >